Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

A transferrin receptor-based vector enables robust Type-II membrane protein display on mammalian cells.

Created on 03 Jul 2026

Authors

Alexander J Sedgwick, James Roest, Geoff Zhang, Gavin J Wright, Christopher Langendorf, Alexander D Barrow, Julian P Vivian

Published in

Biochemical and biophysical research communications. Volume 829. Pages 154215. Jul 01, 2026. Epub Jul 01, 2026.

Abstract

Cell surface protein display is widely used in biotechnology as a platform for interrogating and engineering protein function in mammalian systems. Current display systems, including pDisplay™, are based on type-I membrane topology and enforce an extracellular N-terminus and cytosolic C-terminus. While suitable for secreted proteins and antibody fragments, they are incompatible with type-II membrane proteins, which instead possess an inverted topology. Despite encompassing an important class of proteins, type-II proteins lack robust and generalisable surface display tools. Here, we report a transferrin receptor 1 (TfR1)-based vector for type-II membrane protein display in mammalian cells. By leveraging the native cytoplasmic and transmembrane architecture of TfR1, the system enforces a correct type-II topology and enables efficient trafficking to the plasma membrane. Using TMEM106b as a representative type-II protein, we show that TfR1 fusion drives robust cell-surface localisation, confirmed by fluorescence-activated cell sorting and confocal microscopy.

PMID:
42391659
Bibliographic data and abstract were imported from PubMed on 03 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement